BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37658995)

  • 1. Molecular neuropathology: an essential and evolving toolbox for the diagnosis and clinical management of central nervous system tumors.
    Bertero L; Mangherini L; Ricci AA; Cassoni P; Sahm F
    Virchows Arch; 2024 Feb; 484(2):181-194. PubMed ID: 37658995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care.
    Karimi S; Zuccato JA; Mamatjan Y; Mansouri S; Suppiah S; Nassiri F; Diamandis P; Munoz DG; Aldape KD; Zadeh G
    Clin Epigenetics; 2019 Dec; 11(1):185. PubMed ID: 31806041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embryonal tumors in the WHO CNS5 classification: A Review.
    Gianno F; Miele E; Antonelli M; Giangaspero F
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Essentials of Molecular Testing in CNS Tumors: What to Order and How to Integrate Results.
    Feldman AZ; Jennings LJ; Wadhwani NR; Brat DJ; Horbinski CM
    Curr Neurol Neurosci Rep; 2020 May; 20(7):23. PubMed ID: 32445025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of recently described genetic alterations in central nervous system tumors.
    Lucas CG; Solomon DA; Perry A
    Hum Pathol; 2020 Feb; 96():56-66. PubMed ID: 31678207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment: a population-based study.
    Pickles JC; Fairchild AR; Stone TJ; Brownlee L; Merve A; Yasin SA; Avery A; Ahmed SW; Ogunbiyi O; Gonzalez Zapata J; Peary AF; Edwards M; Wilkhu L; Dryden C; Ladon D; Kristiansen M; Rowe C; Kurian KM; Nicoll JAR; Mitchell C; Bloom T; Hilton DA; Al-Sarraj S; Doey L; Johns PN; Bridges LR; Chakrabarty A; Ismail A; Rathi N; Syed K; Lammie GA; Limback-Stanic C; Smith C; Torgersen A; Rae F; Hill RM; Clifford SC; Grabovska Y; Williamson D; Clarke M; Jones C; Capper D; Sill M; von Deimling A; Pfister SM; Jones DTW; Hargrave D; Chalker J; Jacques TS
    Lancet Child Adolesc Health; 2020 Feb; 4(2):121-130. PubMed ID: 31786093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic DNA methylome profiling and the WHO 5
    Frank S; Hench J
    Clin Neuropathol; 2022; 41(4):153-156. PubMed ID: 35670246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal non-meningothelial tumors of the central nervous system: a literature review and diagnostic update of novelties and emerging entities.
    Tauziède-Espariat A; Hasty L; Métais A; Varlet P
    Acta Neuropathol Commun; 2023 Feb; 11(1):22. PubMed ID: 36737790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions.
    Stichel D; Schrimpf D; Casalini B; Meyer J; Wefers AK; Sievers P; Korshunov A; Koelsche C; Reuss DE; Reinhardt A; Ebrahimi A; Fernández-Klett F; Kessler T; Sturm D; Ecker J; Milde T; Herold-Mende C; Witt O; Pfister SM; Wick W; Jones DTW; von Deimling A; Sahm F
    Acta Neuropathol; 2019 Nov; 138(5):827-835. PubMed ID: 31278449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathology of tumors of the central nervous system.
    Kristensen BW; Priesterbach-Ackley LP; Petersen JK; Wesseling P
    Ann Oncol; 2019 Aug; 30(8):1265-1278. PubMed ID: 31124566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study.
    von Hoff K; Haberler C; Schmitt-Hoffner F; Schepke E; de Rojas T; Jacobs S; Zapotocky M; Sumerauer D; Perek-Polnik M; Dufour C; van Vuurden D; Slavc I; Gojo J; Pickles JC; Gerber NU; Massimino M; Gil-da-Costa MJ; Garami M; Kumirova E; Sehested A; Scheie D; Cruz O; Moreno L; Cho J; Zeller B; Bovenschen N; Grotzer M; Alderete D; Snuderl M; Zheludkova O; Golanov A; Okonechnikov K; Mynarek M; Juhnke BO; Rutkowski S; Schüller U; Pizer B; von Zezschwitz B; Kwiecien R; Wechsung M; Konietschke F; Hwang EI; Sturm D; Pfister SM; von Deimling A; Rushing EJ; Ryzhova M; Hauser P; Łastowska M; Wesseling P; Giangaspero F; Hawkins C; Figarella-Branger D; Eberhart C; Burger P; Gessi M; Korshunov A; Jacques TS; Capper D; Pietsch T; Kool M
    Neuro Oncol; 2021 Sep; 23(9):1597-1611. PubMed ID: 34077956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unclassifiable CNS tumors in DNA methylation-based classification: clinical challenges and prognostic impact.
    Drexler R; Brembach F; Sauvigny J; Ricklefs FL; Eckhardt A; Bode H; Gempt J; Lamszus K; Westphal M; Schüller U; Mohme M
    Acta Neuropathol Commun; 2024 Jan; 12(1):9. PubMed ID: 38229158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the Recent Changes in the WHO Classification for Pediatric Brain and Spinal Cord Tumors.
    Halfpenny AM; Wood MD
    Pediatr Neurosurg; 2023; 58(5):337-355. PubMed ID: 36617415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
    Gritsch S; Batchelor TT; Gonzalez Castro LN
    Cancer; 2022 Jan; 128(1):47-58. PubMed ID: 34633681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Events in CNS Tumor Pathology Post-2016 WHO CNS: cIMPACT-NOW Updates and Other Advancements: A Comprehensive Review Plus a Summary of the Salient Features of 2021 WHO CNS 5.
    Ahmad Z; Rahim S; Abdul-Ghafar J; Chundriger Q; Ud Din N
    Int J Gen Med; 2023; 16():107-127. PubMed ID: 36644568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Practical Approach to the Evaluation and Diagnosis of Pediatric CNS Tumors.
    Cotter JA; Viaene AN; Santi M; Hawkins C; Judkins AR
    Pediatr Dev Pathol; 2022; 25(1):6-9. PubMed ID: 33872110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and molecular characterization of a case classified by DNA‑methylation profiling as "CNS embryonal tumor with BRD4-LEUTX fusion".
    Lebrun L; Allard-Demoustiez S; Gilis N; Van Campenhout C; Rodesch M; Roman C; Calò P; Lolli V; David P; Fricx C; De Witte O; Escande F; Maurage CA; Salmon I
    Acta Neuropathol Commun; 2023 Mar; 11(1):46. PubMed ID: 36934287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The 2021 WHO classification of tumours of the central nervous system].
    Figarella-Branger D; Appay R; Metais A; Tauziède-Espariat A; Colin C; Rousseau A; Varlet P
    Ann Pathol; 2022 Oct; 42(5):367-382. PubMed ID: 34865882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rational approach to the CNS tumors diagnostics.
    Krsková L; Šípalová B; Němečková T; Strnadová M; Kalendová T; Kalfusová A; Alexandra ; Malkusová ; Šandová M; Koblížek M; Balko J; Vícha A; Brož P; Jenčová P; Štolová L; Dagmar ; Voříšková ; Belhajová M; Zápotocký M; Sumerauer D; Zámečník J
    Cesk Patol; 2022; 58(3):135-137. PubMed ID: 36224035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas.
    Otani Y; Satomi K; Suruga Y; Ishida J; Fujii K; Ichimura K; Date I
    Brain Tumor Pathol; 2023 Apr; 40(2):56-65. PubMed ID: 37004583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.